Highlights on HIV, TB and COVID-19
Friday June 11, 2021, 9AM- noon (virtual)
Summit Objectives:
To disseminate recent and ongoing HIV- and TB-related research from Uganda (whether PEPFAR-funded or non-PEPFAR funded)
To highlight key findings on COVID-19 and its impact on HIV- and TB- related programs in Uganda
To inform national policies, programs and disease response activities
Participants: US government PEPFAR team and implementing partners, Uganda Ministry of Health (including Public Health Fellowship Program and others), and other Ugandan health researchers.
The Summit featured four sessions led by a set of session co-chairs from PEPFAR Uganda and from key stakeholders including Ministry of Health, Makerere University School of Public Health and others. Each session consisted of a set of multiple five-minute presentations grouped by topic and given by scientists whose submitted presentations were accepted by the organizing committee. Each session began with in
July 9, 2021
By Mohammed Lamorde
Dr. Lamorde is an expert on the management of infectious diseases in developing countries. He is the head of the global health security program at the Infectious Diseases Institute at Makerere University in Kampala, Uganda.
Early in the pandemic, Uganda bought itself precious time at great economic cost to protect its people from Covid-19.
There were lockdowns, international travel was restricted, and border screenings were introduced to prevent entry of the coronavirus. Cases of Covid-19 identified at borders or in communities were isolated, and people who had been in contact with those infected were quarantined and checked on by public health authorities.
剑桥：近半80岁以上老人辉瑞新冠mRNA疫苗两剂后才有效 sina.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.cn Daily Mail and Mail on Sunday newspapers.
Seize the game-changing potential of mRNA vaccines ghtcoalition.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ghtcoalition.org Daily Mail and Mail on Sunday newspapers.